Search filters

List of works by Isabel Alvarez

A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).

scientific article published on 16 November 2016

A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: the METTEN study

scientific article published on 02 November 2018

Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-the Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial

scientific article published on 11 January 2018

Contextualizing pertuzumab approval in the treatment of HER2-positive breast cancer patients

scientific article published on 29 November 2019

Long-Term Follow-Up of the Intergroup Exemestane Study

scientific article published on 3 May 2017

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.

scientific article published on 17 August 2015

Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study

scientific article published on 31 May 2019

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study

scientific article published on 24 February 2016

Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy

scientific article published on 15 May 2018

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

scientific article published on 12 February 2020

SEOM clinical guidelines in metastatic breast cancer 2015.

scientific article

The Allele of rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin

scientific article published on 28 March 2019

Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.

scientific article published on 21 August 2013